Literature DB >> 29512840

Letter in response to: McAlpine J, Leon-Castillo A, Bosse T. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses. J Pathol 2018; 244: 538-549.

Martin Köbel1, Gregg S Nelson2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29512840     DOI： 10.1002/path.5068

Source DB:  PubMed          Journal:  J Pathol        ISSN： 0022-3417            Impact factor:   7.996


× No keyword cloud information.
  4 in total

1.  The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women.

Authors:  Ian S Hagemann; Wei Deng; Richard J Zaino; Matthew A Powell; Camille Gunderson; Casey Cosgrove; Cara Mathews; Michael L Pearl; Steven Waggoner; Rahel Ghebre; Shashikant Lele; Saketh Guntupalli; Angeles Alvarez Secord; Olga Ioffe; Kay Park; Golnar Rasty; Meenakshi Singh; Robert Soslow; William Creasman; David G Mutch
Journal:  Gynecol Oncol       Date:  2021-01-08       Impact factor: 5.482

2.  Selection of endometrial carcinomas for p53 immunohistochemistry based on nuclear features.

Authors:  Eun Young Kang; Nicholas Jp Wiebe; Christa Aubrey; Cheng-Han Lee; Michael S Anglesio; Derek Tilley; Prafull Ghatage; Gregg S Nelson; Sandra Lee; Martin Köbel
Journal:  J Pathol Clin Res       Date:  2021-10-01

3.  Impact of endometrial carcinoma histotype on the prognostic value of the TCGA molecular subgroups.

Authors:  Antonio Travaglino; Antonio Raffone; Cristina Stradella; Rosanna Esposito; Paola Moretta; Cinzia Gallo; Giuliana Orlandi; Luigi Insabato; Fulvio Zullo
Journal:  Arch Gynecol Obstet       Date:  2020-04-15       Impact factor: 2.344

Review 4.  New Insights into Endometrial Cancer.

Authors:  Laura Paleari; Silvia Pesce; Mariangela Rutigliani; Marco Greppi; Valentina Obino; Franco Gorlero; Valerio Gaetano Vellone; Emanuela Marcenaro
Journal:  Cancers (Basel)       Date:  2021-03-24       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.